Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Spiperone

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Spiperone
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • Rx-only (JP)
Pharmacokinetic data
MetabolismHepatic
ExcretionRenal
Identifiers
  • 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.010.931Edit this at Wikidata
Chemical and physical data
FormulaC23H26FN3O2
Molar mass395.478 g·mol−1
3D model (JSmol)
  • c1ccc(cc1)N2CNC(=O)C23CCN(CC3)CCCC(=O)c4ccc(cc4)F
  • InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29) checkY
  • Key:DKGZKTPJOSAWFA-UHFFFAOYSA-N checkY
  (verify)

Spiperone, also known asspiroperidol and sold under the brand nameSpiropitan ((JP)) is atypical antipsychotic of thebutyrophenone family related tohaloperidol.[1] It is approved for clinical use inJapan as a treatment forschizophrenia.[2]

Pharmacology

[edit]
Spiperone at targets[3]
ReceptorKi (nM)Notes
5-HT1A17.3
5-HT1B995
5-HT1D2397
5-HT1E5051
5-HT1F3.98
5-HT2A1.17
5-HT2B0.8–1114.20.8 is bovine[4]
5-HT2C922.9
5-HT3>10000Rat/other
5-HT5A2512Mouse
5-HT61590Rat
5-HT7109.8
α1A20.4
α1B3.09
α1D8.32
D1398.5
D20.16
D30.34
D41.39
D54500
H1272
σ353

Spiperone interacts with variousmonoamine receptors.[5][3]

Additionally, spiperone was identified by compound screening to be an activator of Ca2+ activated Cl channels (CaCCs), thus a potential target for therapy ofcystic fibrosis.[6]

Derivatives

[edit]

N-Methylspiperone (NMSP) is a derivative of spiperone that is used to study thedopamine andserotonin neurotransmitter system. Labeled with the radioisotopecarbon-11, it can be used forpositron emission tomography.[7]

See also

[edit]

References

[edit]
  1. ^Zheng LT, Hwang J, Ock J, Lee MG, Lee WH, Suk K (December 2008)."The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production".Journal of Neurochemistry.107 (5):1225–1235.doi:10.1111/j.1471-4159.2008.05675.x.PMID 18786164.
  2. ^"Mirtazapine".Martindale: The Complete Drug Reference. The Royal Pharmaceutical Society of Great Britain. 12 September 2011. Retrieved4 November 2013.
  3. ^abRoth BL, Driscol J (12 January 2011)."PDSP Ki Database".Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Archived fromthe original on 8 November 2013. Retrieved4 November 2013.
  4. ^Bender AM, Parr LC, Livingston WB, Lindsley CW, Merryman WD (August 2023)."2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery".J Med Chem.66 (16):11027–11039.doi:10.1021/acs.jmedchem.3c01178.PMC 11073569.PMID 37584406.
  5. ^Glennon RA (January 1987). "Central serotonin receptors as targets for drug research".J Med Chem.30 (1):1–12.doi:10.1021/jm00384a001.PMID 3543362.Table II. Affinities of Selected Phenalkylamines for 5-HT1 and 5-HT2 Binding Sites
  6. ^Liang L, MacDonald K, Schwiebert EM, Zeitlin PL, Guggino WB (January 2009)."Spiperone, identified through compound screening, activates calcium-dependent chloride secretion in the airway".American Journal of Physiology. Cell Physiology.296 (1):C131 –C141.doi:10.1152/ajpcell.00346.2008.PMC 4116347.PMID 18987251.
  7. ^Andrée B, Nyberg S, Ito H, Ginovart N, Brunner F, Jaquet F, et al. (August 1998). "Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain".Journal of Clinical Psychopharmacology.18 (4):317–323.doi:10.1097/00004714-199808000-00012.PMID 9690698.
Typical
Disputed
Atypical
Others
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Retrieved from "https://en.wikipedia.org/w/index.php?title=Spiperone&oldid=1296122829"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp